Grant Chamberlain joined Ziegler in 2015 as a managing director in the Healthcare Investment Banking Practice. With over 25 years of investment banking experience, Grant has dedicated the majority of his career to advising HCIT and tech-enabled outsourced services companies with particular focus on transactions with telehealth companies such as Vimly, CXC, TM2U, Somnoware, Avera eCare, Philips Lifeline / ConnectAmerica, Tridiuum, Anelto, SmartMeter, CancerIQ, Validic, Doctible, CentralLogic, SCI, Regroup, Forefront, Basys, Airstrip, Forefront, IRIS, MDLIVE and Voalte.
Prior to Ziegler, Grant led the mHealth sector coverage at Raymond James – which included telehealth, remote monitoring and wireless healthcare solutions – after spending 25 years advising HCIT and tech-enabled outsourced services companies on a broad variety of M&A, joint ventures/partnerships and private financings. Additionally, Grant has completed dozens of transactions in the physician practice management space with a specific concentration in oncology, having closed over 15 deals in that sector in his career.
Prior to Raymond James, Grant was a principal at Shattuck Hammond Partners, which was acquired by Morgan Keegan. He was also a part of the corporate finance group of General Electric Capital Corporation and the financial services division of GE Medical Systems.
In addition, Grant is an elected Director of the ATA, the leading international advocate for the use of advanced remote medical technologies. He is also on the Board of Directors for The MAVEN Project, which uses telehealth and a network of volunteer physicians affiliated with the nation’s foremost medical school alumni associations to improve healthcare access for underserved populations.
Grant earned a B.A. in finance and investment banking from University of Wisconsin-Madison.